New hope for tough cancers: testing a Triple-Threat treatment
Disease control
Recruiting now
This study is testing a combination of three drugs—trastuzumab, serplulimab, and chemotherapy—for people with advanced HER2-positive biliary tract cancer or bladder cancer that has spread and no longer responds to standard treatments. The goal is to see if this three-drug approac…
Phase: PHASE2 • Sponsor: Xiujuan Qu • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC